Ranbaxy Laboratories Limited
|Chlorpheniramine Maleate||8 mg|
|Phenylpropanolamine HCL||50 mg|
Click on the API name to know their properties
|Composit uses/ indication of COLDACT :|
Acute urticaria, Advanced ovarian cancer, Allergic conjunctivitis, Atopic dermatitis, Chronic urticaria, Emergency treatment of anaphylactic reaction, Seasonal allergic rhinitis, Transcervical operative procedures in first trimester.
Appetite suppresser, Cold, Congestion, Cough, Urinary incontinence.
|Composit contra indication of COLDACT :|
|Composit side effects of COLDACT :|
Jaundice, Sinus tachycardia, Seizures, Hypertension, Jaundice, CNS stimulation. Bone marrow suppression, Hypotension, Convulsions, Coma, Urinary retention, Unconsciousness, Fever, Dryness of mucous, Flushing membrane, Pupillary dilatation. Vomiting, Nausea, Sedation, Facial dyskinesias, Xerostomia, Abdominal pain, Constipation, Blurred vision, Dry mouth, Drowsiness, Restlessness, Palpitation, Dry mouth, Blood dyscrasias.
Hypertension, Epileptic seizures, Hallucinations, Psychosis, Dizziness, Headache, Nausea, Palpitation, Termors, Chest tightness.
|Composit caution of COLDACT :|
Elderly, pylori duodenal obstruction, angle-closure glaucoma, urinary retention, prostatic hyperplasia, epilepsy, renal and hepatic impairment. May affect performance of skilled tasks. BPH, bladder neck obstruction, hypertension. Pregnancy, lactation.
Use phenylpropanolamine only in acute conditions, not longer than 3 to 5 days. infants, children and in cardiac patients. Avoid continuous use for longer than 3 months.
Glaxo Smithkline Pharmaceuticals Ltd.